Panel Discussion | Valves, Intra-Atrial Shunts and Heart Failure

Sunday, March 8, 2026

12:18 PM - 12:33 PM EST

Location: Georgetown

Moderator(s)

JoAnn Lindenfeld, MD

Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AbioMed: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); AskBio: Consulting Fees (e.g., advisory boards) (Ongoing); Axon: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Cordio: Consulting Fees (e.g., advisory boards) (Ongoing); CVRx: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Intershunt,: Consulting Fees (e.g., advisory boards) (Ongoing); Kestra: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Vectorious: Consulting Fees (e.g., advisory boards) (Ongoing); Volumetrix: Consulting Fees (e.g., advisory boards) (Ongoing); VWave: Consulting Fees (e.g., advisory boards) (Ongoing); Whiteswell: Consulting Fees (e.g., advisory boards) (Ongoing)
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Disclosure(s): No financial relationships to disclose
James Udelson, MD

Chief, Division of Cardiology
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure(s): Alleviant: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); FIRE1: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Reprieve: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Panel Discussant(s)

Vijay Iyer, MD, PhD

Associate Professor
University at Buffalo
East Amherst, New York, United States

Disclosure information not submitted.
Navin K. Kapur, MD, FSCAI FAHA FACC

Professor of Medicine
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

Disclosure information not submitted.
Scott M. Lilly, MD PhD

Professor
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States

Disclosure(s): Cardiac Dimensions: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
JoAnn Lindenfeld, MD

Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AbioMed: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); AskBio: Consulting Fees (e.g., advisory boards) (Ongoing); Axon: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Cordio: Consulting Fees (e.g., advisory boards) (Ongoing); CVRx: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Intershunt,: Consulting Fees (e.g., advisory boards) (Ongoing); Kestra: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Vectorious: Consulting Fees (e.g., advisory boards) (Ongoing); Volumetrix: Consulting Fees (e.g., advisory boards) (Ongoing); VWave: Consulting Fees (e.g., advisory boards) (Ongoing); Whiteswell: Consulting Fees (e.g., advisory boards) (Ongoing)
Miguel Pinilla Vera, MD

Advanced Heart Failure Cardiologist
Medstar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

JoAnn Lindenfeld, MD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AbioMed: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); AskBio: Consulting Fees (e.g., advisory boards) (Ongoing); Axon: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Cordio: Consulting Fees (e.g., advisory boards) (Ongoing); CVRx: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Intershunt,: Consulting Fees (e.g., advisory boards) (Ongoing); Kestra: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Merck Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Vectorious: Consulting Fees (e.g., advisory boards) (Ongoing); Volumetrix: Consulting Fees (e.g., advisory boards) (Ongoing); VWave: Consulting Fees (e.g., advisory boards) (Ongoing); Whiteswell: Consulting Fees (e.g., advisory boards) (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose

James Udelson, MD: Alleviant: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); FIRE1: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Reprieve: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Scott M. Lilly, MD PhD: Cardiac Dimensions: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Miguel Pinilla Vera, MD: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)